Abiomed, Inc. provided earnings guidance for the fiscal year 2023. For the period, the company expects revenue to be in the range $1.13 billion and $1.17 billion or 10% to 14% growth compared to fiscal year 2022.
Abiomed, Inc.
Equities
ABMD
US0036541003
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+12.80% | 227B | |
+13.45% | 192B | |
+18.22% | 136B | |
+28.30% | 108B | |
+1.67% | 64.07B | |
+17.81% | 52.1B | |
+7.04% | 51.87B | |
+10.77% | 44.33B | |
+6.08% | 36.75B |